GALT: Galectin Therapeutics Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 84.03
Enterprise Value ($M) 177.36
Book Value ($M) -103.07
Book Value / Share -1.63
Price / Book -0.82
NCAV ($M) -103.31
NCAV / Share -1.64
Price / NCAV -0.81

Profitability (mra)
Return on Invested Capital (ROIC) -14.82
Return on Assets (ROA) -1.82
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.49
Current Ratio 0.49

Balance Sheet (mrq) ($M)
Current Assets 17.25
Assets 17.50
Liabilities 120.56
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -42.43
Net Income -47.05
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -41.77
Cash from Investing 0.00
Cash from Financing 31.23

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-31 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-05 35,769 193,766 18.46
2025-05-02 20,390 98,382 20.73
2025-04-30 23,600 145,987 16.17

(click for more detail)

Similar Companies
FENC – Fennec Pharmaceuticals Inc. FLGC – Flora Growth Corp.
FTLF – FitLife Brands, Inc. GDTC – CytoMed Therapeutics Limited
GELS – Gelteq Limited


Financial data and stock pages provided by
Fintel.io

Finpedia: Galectin Therapeutics



This entry was posted in . Bookmark the permalink.